Pharm-Olam nabs PE investment amid 'market void' for mid-tier CROs

Pharm-Olam nabs PE investment amid ‘market void’ for mid-tier CROs

Pharm-Olam has secured an investment from Quad-C Management as the private equity firm eyes add-on acquisitions to complement organic growth.

(Image: iStock/Tsyhun)

Pharmaron acquires Xceleron as it looks to provide 'end-to-end' services

Image: iStock/rudall30

Out with the old, in with the new? Lonza sells peptide biz, Recipharm adds Indian ops

Top CRO M&A activity of 2016

Top CRO M&A activity of 2016

(Image: iStock/travellinglight)

Evotec completes Cyprotex acquisition

Silica are small particles based on silicon dioxide used in a variety of industries. (Image: iStock/olando_o)

CMO Evonik acquires silica business for $630m


Lonza confirms interest in Capsugel takeover

The deal is the latest in a string of private equity investment into the market. (Image: iStock/jansucko)

Private equity snags another CRO, Premier Research

(Image: iStock/choness)

Is industry consolidation stifling pharma innovation?

Parexel has entered into a definitive agreement to acquire ExecuPharm. (Image: iStock/Ridofranz)

Parexel to acquire functional service provider ExecuPharm

More Consolidation